A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis
Clinical trial NCT04544449 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04544449
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-26
- Primary completion
- 2025-09-17
- Enrollment
- 985
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.